Groundbreaking Partnership for Health Advancement

In a game-changing move for global health, Jiangsu Recbio Technology, a top-tier Chinese biopharmaceutical company, has forged a licensing agreement with Biological E. Limited (BE), a premier Indian vaccine manufacturer. This exciting partnership will kickstart the production and distribution of the Recombinant 9-valent HPV (HPV9) vaccine, known as REC603.

What’s Inside This Innovative Vaccine?

The HPV9 vaccine is ingeniously engineered to guard against nine strains of the Human Papillomavirus—culprits behind cervical, vulvar, vaginal, anal, and oropharyngeal cancers, along with causing genital warts. This means not only a potential decrease in cancer rates but also an overall improvement in women's health globally.

Empowering Local Production and Global Outreach

As part of their collaboration, Recbio will bestow BE with all necessary resources, including Drug Substance (DS) and technology for formulation, filling, and packaging. This comprehensive transfer includes a future initiative for DS production, ensuring a robust supply chain. BE gains exclusive rights to commercialize the vaccine across India, along with participation in UNICEF and PAHO tenders, opening doors to international markets.

A Timely Intervention in Cancer Prevention

Amid an escalating global call for effective cervical cancer prevention, this partnership couldn't come at a better time. Recbio's continued support in clinical development and navigating regulatory approvals ensures that BE can swiftly transition into large-scale production once the technology transfer is complete.

A Bright Future Ahead for HPV Vaccination

This historic collaboration not only marks a crucial step for Recbio in penetrating the Indian and international markets but also underscores its commitment to innovative solutions in vaccine development. With the shared goal of making the HPV9 vaccine more accessible and affordable, this partnership could immensely impact public health, saving countless lives and improving health standards worldwide.